Gordon David N.

CIK 00017511671 companyWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001751167

Recent Transactions

33 trades

Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-07-13$16.98/sh−2,631→ 147,447 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-07-02−6,000→ 6,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-07-02+6,000→ 150,078 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-02$21.50/sh−31,114→ 150,878 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-02$22.26/sh−6,800→ 144,078 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-01−87,500→ 0 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-01$22.71/sh−9,115→ 186,877 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-01$23.57/sh−4,885→ 181,992 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-01+87,500→ 195,992 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2021-03-02−8,297→ 24,892 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-03-02+8,297→ 110,772 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-03-02$23.25/sh−2,280→ 108,492 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-03-01$24.06/sh−5,660→ 102,475 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2021-03-01+99,500→ 99,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2021-03-01+28,400→ 28,400 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2021-03-01−20,600→ 41,200 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-03-01+20,600→ 108,135 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-07-02$1.50/sh−1,360→ 87,535 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-07-02+6,000→ 88,895 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-07-02−6,000→ 12,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-01+87,500→ 106,940 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-01$1.32/sh−24,045→ 82,895 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-06-01−87,500→ 87,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02+20,600→ 24,952 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02$1.26/sh−5,512→ 19,440 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02−20,600→ 61,800 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2020-03-02+116,160→ 116,160 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+33,189→ 33,189 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2019-10-30+175,000→ 175,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2019-07-02+6,000→ 6,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2019-07-02−6,000→ 18,000 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2019-07-02$2.34/sh−1,648→ 4,352 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2019-03-01+82,400→ 82,400 total

Companies

Aclaris Therapeutics, Inc.
Chief Medical Officer
$ACRS

Recent Filings

Address

640 LEE ROAD, SUITE 200

WAYNE, PA, 19087

View on SEC.gov